| 55.38 0 (0%) | 09-25 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 78.05  |
1-year : | 89.46 |
| Resists | First : | 66.82 |
Second : | 76.59 |
| Pivot price | 57.08 |
|||
| Supports | First : | 51 | Second : | 42.44 |
| MAs | MA(5) : | 55.24  |
MA(20) : | 60.35 |
| MA(100) : | 67 |
MA(250) : | 72.04 |
|
| MACD | MACD : | -4.5 |
Signal : | -4.5 |
| %K %D | K(14,3) : | 23.2 |
D(3) : | 22.3 |
| RSI | RSI(14): 30.3 | |||
| 52-week | High : | 89.83 | Low : | 51 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ COO ] has closed above bottom band by 41.7%. Bollinger Bands are 102.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 16 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 56.22 - 56.48 | 56.48 - 56.73 |
| Low: | 54.33 - 54.64 | 54.64 - 54.93 |
| Close: | 54.88 - 55.36 | 55.36 - 55.81 |
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Sun, 27 Sep 2026
The Cooper Companies, Inc. (COO) stock price, news, quote and history - Yahoo Finance UK
Sat, 26 Sep 2026
The Cooper Companies, Inc. (COO) latest stock news and headlines – Yahoo Finance - Yahoo Finance Singapore
Fri, 25 Sep 2026
The Cooper Companies, Inc. (COO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Thu, 24 Sep 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Cooper Companies, Inc. - COO - PR Newswire
Thu, 24 Sep 2026
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - natlawreview.com
Thu, 24 Sep 2026
CooperCompanies (COO) Keeps CooperSurgical and Expands Buybacks. What Did the Strategic Review Reveal? - Insider Monkey
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 195 (M) |
| Shares Float | 194 (M) |
| Held by Insiders | 0.6 (%) |
| Held by Institutions | 109.2 (%) |
| Shares Short | 7,640 (K) |
| Shares Short P.Month | 7,920 (K) |
| EPS | 1.17 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 42.27 |
| Profit Margin | 5.5 % |
| Operating Margin | -2.9 % |
| Return on Assets (ttm) | 2.5 % |
| Return on Equity (ttm) | 2.8 % |
| Qtrly Rev. Growth | 7.9 % |
| Gross Profit (p.s.) | 14.2 |
| Sales Per Share | 21.68 |
| EBITDA (p.s.) | 4.54 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 953 (M) |
| Levered Free Cash Flow | 424 (M) |
| PE Ratio | 46.93 |
| PEG Ratio | 0.6 |
| Price to Book value | 1.31 |
| Price to Sales | 2.55 |
| Price to Cash Flow | 11.33 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|